Skip to main content
. 2021 Jul 28;100(4):403–413. doi: 10.1111/aos.14993

Table 1.

Patient group characteristics.

Uveitis aetiology Mean age (SD) Male/Female
All intraocular inflammation (N = 69) 59 (17) 29/40
Annotated intraocular inflammation (n = 47) 59 (16) 17/30
Blind tested intraocular inflammation (n = 22) 59 (20) 12/10
Cohort 1 (N = 47; annotated)
Idiopathic Uveitis (n = 8) 64 (12) 2/6
(P)VRL Uveitis (n = 7) 57 (21) 5/2
Granulomatous Uveitis (N = 21) 61 (15) 4/17
  • TB‐associated Uveitis (n = 6)

56 (14) 3/3
  • Sarcoid Uveitis (n = 15)

63 (13) 1/14
Uveitis associated with systemic disease (n = 2)* 62 (21) 0/2
Non‐TB Infectious Uveitis (n = 6) 46 (21) 6/0
Other (n = 3)** 64 (8) 0/3
Cohort 2 (N = 22; Blind tested)
Idiopathic Uveitis (n = 6) 63 (14) 3/3
(P)VRL Uveitis (n = 5) 73 (14) 4/1
Uveitis associated with systemic disease (n = 2)*** 40 (6) 1/1
Non‐TB Infectious Uveitis (n = 5) 59 (20) 2/3
Sarcoid Uveitis (n = 2) 32 (16) 1/1
Leukemia (n = 1) 85 (n/a) 1/0
Other (n = 1)**** 77 (n/a) 0/1
Treated (P)VRL Uveitis (n = 2) 67 (12) 1/1

(P)VRL = primary vitreoretinal lymphoma, SD = standard deviation, TB = tuberculosis.

*

One multiple sclerosis patient, one colitis ulcerosa patient.

**

One vasoproliferative tumour patient, one patients with floaters and one retinal detachment patient.

***

Two multiple sclerosis patients.

****

One patients with a complicated cataract surgery.